INTRODUCTION: Acquired haemophilia is a rare autoimmune disorder caused by autoantibodies directed in the majority of the cases against clotting factor VIII. This disorder is characterised by the sudden onset of bleeding that not rarely may be life-threatening and need transfusion support. Most reports on this condition describe the need for blood transfusions during the acute, haemorrhagic phase, but the number of transfused red cell units is often unknown. PATIENTS AND METHODS: In the last 5 years, 14 patients with acquired haemophilia A were identified in the transfusion and haemophilia centres of Verona and Castelfranco Veneto. The transfusion support for these 14 patients was analyzed in this retrospective survey. RESULTS: The 14 patients required a total of 183 red cell units. The average transfusion requirement was 13 red cells units/patient, with a range from 0 to 38 units. CONCLUSIONS: Eleven of the 14 patients studied needed strong transfusion support to enable any further management of the haemorrhages, as well as for eradication treatment of the autoantibodies to factor VIII. A relevant part of the management of haemorrhagic symptoms as well as the first choice for any further treatment (bleeding or the cure of the underlying disease) is transfusion of red blood cells.
INTRODUCTION: Acquired haemophilia is a rare autoimmune disorder caused by autoantibodies directed in the majority of the cases against clotting factor VIII. This disorder is characterised by the sudden onset of bleeding that not rarely may be life-threatening and need transfusion support. Most reports on this condition describe the need for blood transfusions during the acute, haemorrhagic phase, but the number of transfused red cell units is often unknown. PATIENTS AND METHODS: In the last 5 years, 14 patients with acquired haemophilia A were identified in the transfusion and haemophilia centres of Verona and Castelfranco Veneto. The transfusion support for these 14 patients was analyzed in this retrospective survey. RESULTS: The 14 patients required a total of 183 red cell units. The average transfusion requirement was 13 red cells units/patient, with a range from 0 to 38 units. CONCLUSIONS: Eleven of the 14 patients studied needed strong transfusion support to enable any further management of the haemorrhages, as well as for eradication treatment of the autoantibodies to factor VIII. A relevant part of the management of haemorrhagic symptoms as well as the first choice for any further treatment (bleeding or the cure of the underlying disease) is transfusion of red blood cells.
Authors: M Franchini; D Girelli; O Olivieri; G Castaman; G Lippi; G Poli; G L Salvagno; G Tagariello; A Giuffrida; M de Gironcoli; M Morfini; E Berntorp; G Gandini Journal: Haemophilia Date: 2006-07 Impact factor: 4.287
Authors: P Bossi; J Cabane; J Ninet; R Dhote; T Hanslik; O Chosidow; C Jouan-Flahault; M H Horellou; F Leynadier; E Liozon; J Pouchot; J P Robin; F Sanderson; A Schaeffer; D Sicard; F Staikowsky; B Wechsler; R Zittoun Journal: Am J Med Date: 1998-11 Impact factor: 4.965